Pharmaceutical Biotechnology

Daten

Offizielle Daten in der Fachveröffentlichung für das folgende akademische Jahr: 2024-2025

Lehrbeauftragte/r

  • Pongrácz Judit Erzsébet

    professor,
    Faculty of Health Sciences - Institute of Health Science, Department of Public Health

Semesterwochenstunden

Vorlesungen: 14

Praktika: 0

Seminare: 14

Insgesamt: 28

Fachangaben

  • Kode des Kurses: OPG-GBI-T
  • 2 kredit
  • Pharmacy
  • Pharmaceutical theoretical module and practical skills modul
  • spring
Voraussetzungen:

OPG-GAI-T finished

Zahl der Kursteilnehmer für den Kurs:

min. 1 – max. 60

Thematik

The aim of the course is to provide basic understanding of modern, biotechnology based drug development. The course provides insight into drug development and production using the methodological and technical arsenal of biotechnology in the pharmaceutical industry.

Vorlesungen

  • 1. Introduction. Significance of biotechnology in pharmaceutical sciences - Bóvári-Biri Judit
  • 2. Recombinant DNA technology in drug development I. - Bóvári-Biri Judit
  • 3. Recombinant DNA technology in drug development II. - Bóvári-Biri Judit
  • 4. Recombinant DNA technology in drug development II. - Bóvári-Biri Judit
  • 5. Recombinant proteins 1 - Garai Kitti
  • 6. Recombinant proteins 2 - Garai Kitti
  • 7. Monoclonal antibodies 1 - Bóvári-Biri Judit
  • 8. Monoclonal antibodies 2 - Bóvári-Biri Judit
  • 9. Vaccines 1 - Bóvári-Biri Judit
  • 10. Vaccines 2 - Bóvári-Biri Judit
  • 11. Cell therapy 1 - Bóvári-Biri Judit
  • 12. Cell therapy 2 - Garai Kitti
  • 13. Plant biotechnology for production therapy of small molecular drugs I. - Garai Kitti
  • 14. Plant biotechnology for production therapy of small molecular drugs II. - Garai Kitti

Praktika

Seminare

  • 1. Introduction. Significance of biotechnology in pharmaceutical sciences - Bóvári-Biri Judit
  • 2. Recombinant DNA technology in drug development I. - Bóvári-Biri Judit
  • 3. Recombinant DNA technology in drug development II. - Bóvári-Biri Judit
  • 4. Recombinant DNA technology in drug development II. - Bóvári-Biri Judit
  • 5. Recombinant proteins 1 - Garai Kitti
  • 6. Recombinant proteins 2 - Garai Kitti
  • 7. Monoclonal antibodies 1 - Bóvári-Biri Judit
  • 8. Monoclonal antibodies 2 - Bóvári-Biri Judit
  • 9. Vaccines 1 - Garai Kitti
  • 10. Vaccines 2 - Garai Kitti
  • 11. Cell therapy 1 - Bóvári-Biri Judit
  • 12. Cell therapy 2 - Bóvári-Biri Judit
  • 13. Plant biotechnology for production therapy of small molecular drugs I. - Garai Kitti
  • 14. Plant biotechnology for production therapy of small molecular drugs II. - Garai Kitti

Materialien zum Aneignen des Lehrstoffes

Obligatorische Literatur

Vom Institut veröffentlichter Lehrstoff

Lecture ppt

Seminar ppt

Skript

Pharmaceutical Biotechnology departmental notes

Empfohlene Literatur

Voraussetzung zum Absolvieren des Semesters

75% participation on lectures and tests on seminars

Semesteranforderungen

On the 7th week, written test

Möglichkeiten zur Nachholung der Fehlzeiten

None

Prüfungsfragen

Meetstreet, Teams, Moodle

Prüfer

  • Bóvári-Biri Judit
  • Garai Kitti
  • Kvell Krisztián

Praktika, Seminarleiter/innen

  • Bóvári-Biri Judit
  • Draskóczi Lilla Gréta
  • Garai Kitti
  • Papp Alexandra